4/A

PRIMARY DOCUMENT

Company: IONIS PHARMACEUTICALS INC
Filed: July 3, 2019
Period of Report: July 1, 2019
Accession Number: 0000874015-19-000112

View Document ↗ View on SEC.gov ↗